Infinimmune
eDR60Effective DR: 60/100. Below median. Measured by StartupHub.ai. Median 68.Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Trust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
About
Infinimmune is a biotechnology company focused on discovering and developing next-generation antibody therapeutics directly from the human immune system. They leverage their proprietary Anthrobody® platform and GLIMPSE™ antibody language model to identify and optimize fully human antibodies for the treatment of atopic dermatitis, other inflammatory diseases, and cancer.
Key facts
At-a-glance profile data
- Website
- infinimmune.com
- Headquarters
- Alameda, United States
- Founded
- 2017
- Employees
- 22
- Total funding
- $75M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Aug 2026 | Series A | $75M | - |
Tech stack
Detected on infinimmune.com, last scanned 15 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Frequently asked
What is Infinimmune's Effective Domain Rating?
StartupHub's Effective Domain Rating for Infinimmune is 60 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 20, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Infinimmune trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Infinimmune is 82 out of 100, based on site security posture and privacy practices.
How much funding has Infinimmune raised?
Infinimmune has raised a total of $75M in funding. The most recent round on record is Series A.
How many employees does Infinimmune have?
Infinimmune has approximately 22 people on record.